3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
3
Desmoid Tumors
3
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Disease
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Unresectable Solid Tumors
1
Thyroid Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Respiratory Aspiration
1
Pancreatic Adenocarcinoma Locally Advanced
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypesthesia
1
High-Burden Metastatic Solid Tumors
1
Interventions
Gemcitabine
33
Cisplatin
28
pembrolizumab
19
durvalumab
17
Oxaliplatin
16
Fluorouracil
16
Leucovorin
14
Magnetic Resonance Spectroscopy
13
Specimen Handling
9
Biopsy
9
lenvatinib
7
Nivolumab
7
Capecitabine
7
Taxes
6
Paclitaxel
6
Irinotecan
6
fludarabine
5
Folfox protocol
5
Drug Therapy
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
pemigatinib
4
Ipilimumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
Cyclophosphamide
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
tremelimumab
3
olaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Cryosurgery
×
1 year
×
Clear all
NCT07070700
2025-08-12
CASTLE-ZS-02
Fudan University
Phase 2
Recruiting
56 enrolled